IP 253 (Ranitidine 150 mg)
Pill imprint IP 253 has been identified as Ranitidine hydrochloride 150 mg.
Ranitidine is used in the treatment of gerd; erosive esophagitis; zollinger-ellison syndrome; duodenal ulcer; gastric ulcer maintenance treatment (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 150 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for IP 253
- 150 mg
- 9.00 mm
- Rx and/or OTC
- Drug Class:
- H2 antagonists
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Amneal Pharmaceuticals
- National Drug Code (NDC):
|NDC Code||Manufacturer / Repackager|
|66267-0188||Nucare Pharmaceuticals Inc (repackager)|
|68071-1321||Nucare Pharmaceuticals Inc (repackager)|
Note: Inactive ingredients may vary.
More about ranitidine
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.